RAISE-Lung (Respiratory Aerosol Infrared, AI-enabled Sensing for Early detection)
| Reference number | |
| Coordinator | PExA AB |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | November 2025 - December 2026 |
| Status | Ongoing |
| Venture | Deepened international collaborations |
| Call | Deepened collaboration with USA, UK and Singapore within Health and Life Science |
Purpose and goal
Purpose: to prepare a Sweden–UK collaboration enabling non-invasive, near-patient diagnostics for early lung-cancer detection by combining PExA sampling of exhaled-particle biomarkers with compact IR sensing (and, longer-term, AI). Goals: formalise the collaboration (MoU), harmonise methods (SOP v1.0/Interface Matrix), run limited Research Use Only (RUO) feasibility, and produce a regulatory roadmap plus funding-ready materials.
Expected effects and result
Results: signed Memorandum of Understanding (MoU); harmonised methods via Standard Operating Procedure v1.0 (SOP v1.0). Research Use Only (RUO) feasibility data (e.g., signal-to-noise ratio, coefficient of variation, limit of detection); a regulatory roadmap; and proposal shells (EIC/Eurostars). Effects: deeper Sweden–United Kingdom collaboration, lower technical/regulatory risk, stronger 2026–27 funding competitiveness, and a clear step toward rapid, non-invasive early lung-cancer diagnostics.
Planned approach and implementation
The project is organised into four WPs. (1) Formalise the collaboration with agreements, governance, and a shared set of requirements. (2) Laboratory-based feasibility phase: adapt the sample–sensor workflow, establish initial operating procedures, and verify basic functionality. (3) Develop a regulatory roadmap and gap analysis, plus drafts for larger funding applications. (4) Package results, recruit new collaboration partners, and prepare the next phase. Monthly governance.